The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans

NCT00872599 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: fenofibrate
DRUG: Placebo

Sponsor

Vanderbilt University

Collaborators

[object Object]